NAII, US6388423021

Natural Alternatives International stock at EUR 0.99 after fiscal loss

Published on 10/30/2026 at 02:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Natural Alternatives International stock is in focus after a difficult fiscal 2026 quarter. A non-cash impairment charge weighed heavily on profitability.

Results and strategic response

  • Fiscal 2026 sales increased, but the latest quarter showed a wider loss and lower gross margin.
  • Management is consolidating U.S. manufacturing and reviewing strategic alternatives, including a possible sale.
NAII, US6388423021, Illustration mit AI erstellt.

Natural Alternatives International reported higher fiscal 2026 sales but a substantially wider fourth-quarter loss, according to a Nasdaq analysis published September 29, 2026. The report said fiscal-year sales rose to USD 142.5 million, while fourth-quarter sales increased to USD 34.5 million.

Sales growth did not improve profit

The company posted a fourth-quarter net loss of USD 13.5 million, or USD 2.23 per share, compared with a loss of USD 7.2 million, or USD 1.20 per share, in the prior-year quarter. Results included a USD 10.4 million non-recurring, non-cash impairment charge related to the underused Carlsbad manufacturing facility.

Excluding that charge, the quarterly loss would have been USD 3.1 million, or USD 0.52 per share. Gross profit declined to USD 1.7 million from USD 3.5 million, and the gross margin fell to 5% from 10.4%. The figures show that higher sales did not translate into improved operating performance.

Manufacturing footprint under review

Natural Alternatives is consolidating its U.S. manufacturing operations into its Vista, California, facility and expects to sell the Carlsbad site. Management said the move is intended to reduce excess capacity, lower debt and strengthen liquidity. The company is also conducting a strategic review that may include growth initiatives, mergers, acquisitions, joint ventures or a sale.

Liquidity was weaker at the end of fiscal 2026. Cash and cash equivalents stood at USD 7.4 million on June 30, 2026, compared with USD 12.3 million a year earlier. Adjusted EBITDA was negative USD 3.4 million for fiscal 2026, versus negative USD 2.1 million in fiscal 2025.

At Lang & Schwarz, the stock was quoted at EUR 0.99 on October 29, 2026, at 22:59 Berlin time. The bid was EUR 0.81 and the ask EUR 1.18. Investors should distinguish this euro quote from the company's U.S. reporting currency and from the underlying operating developments. The real-time quote of Natural Alternatives International stock provides the latest available market reference.

Natural Alternatives International at a glance

  • Company: Natural Alternatives International, Inc.
  • ISIN: US6388423021
  • Ticker: NAII
  • Lang & Schwarz quote: EUR 0.99 on October 29, 2026, at 22:59 Berlin time
  • Fiscal 2026 sales: USD 142.5 million
  • Fiscal 2026 adjusted EBITDA: negative USD 3.4 million

Broader market conditions remain an important backdrop for small-cap U.S. companies, without determining the outcome of this individual restructuring and strategic review.

More news and analyses on Natural Alternatives International stock

Disclaimer...
en | US6388423021 | NAII | boerse | 70432069 |